Misbahuddin M. Rafeeq

774 total citations
51 papers, 491 citations indexed

About

Misbahuddin M. Rafeeq is a scholar working on Molecular Biology, Genetics and Computational Theory and Mathematics. According to data from OpenAlex, Misbahuddin M. Rafeeq has authored 51 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 10 papers in Genetics and 8 papers in Computational Theory and Mathematics. Recurrent topics in Misbahuddin M. Rafeeq's work include Computational Drug Discovery Methods (8 papers), Cancer therapeutics and mechanisms (4 papers) and Asthma and respiratory diseases (4 papers). Misbahuddin M. Rafeeq is often cited by papers focused on Computational Drug Discovery Methods (8 papers), Cancer therapeutics and mechanisms (4 papers) and Asthma and respiratory diseases (4 papers). Misbahuddin M. Rafeeq collaborates with scholars based in Saudi Arabia, India and Egypt. Misbahuddin M. Rafeeq's co-authors include Hussam Murad, Hamed Habib, Ali M. El‐Halawany, Hossam M. Abdallah, Manoj Kumar Yadav, Khalid Raza, Muhammad Umair, Shaban Ahmad, Qamre Alam and Ahmed Waqas and has published in prestigious journals such as PLoS ONE, Journal of Pharmacology and Experimental Therapeutics and Molecules.

In The Last Decade

Misbahuddin M. Rafeeq

43 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Misbahuddin M. Rafeeq Saudi Arabia 11 168 125 62 52 42 51 491
Shuzhi Wang China 13 274 1.6× 60 0.5× 71 1.1× 108 2.1× 89 2.1× 47 628
Yiheng Wang China 15 325 1.9× 63 0.5× 41 0.7× 38 0.7× 106 2.5× 44 762
Zhe Meng China 12 216 1.3× 116 0.9× 47 0.8× 34 0.7× 46 1.1× 24 635
Thomas M. Moon United States 9 435 2.6× 105 0.8× 23 0.4× 57 1.1× 18 0.4× 13 601
Zeqi Su China 14 280 1.7× 76 0.6× 31 0.5× 26 0.5× 112 2.7× 23 557
Sandro Satta United States 12 265 1.6× 62 0.5× 22 0.4× 37 0.7× 39 0.9× 25 679
José Manuel Cóndor Capcha United States 11 152 0.9× 42 0.3× 25 0.4× 31 0.6× 56 1.3× 23 592
Hisashi Nagai Japan 15 277 1.6× 77 0.6× 56 0.9× 132 2.5× 27 0.6× 47 692
Lili Dong China 13 184 1.1× 72 0.6× 38 0.6× 18 0.3× 29 0.7× 28 520

Countries citing papers authored by Misbahuddin M. Rafeeq

Since Specialization
Citations

This map shows the geographic impact of Misbahuddin M. Rafeeq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Misbahuddin M. Rafeeq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Misbahuddin M. Rafeeq more than expected).

Fields of papers citing papers by Misbahuddin M. Rafeeq

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Misbahuddin M. Rafeeq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Misbahuddin M. Rafeeq. The network helps show where Misbahuddin M. Rafeeq may publish in the future.

Co-authorship network of co-authors of Misbahuddin M. Rafeeq

This figure shows the co-authorship network connecting the top 25 collaborators of Misbahuddin M. Rafeeq. A scholar is included among the top collaborators of Misbahuddin M. Rafeeq based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Misbahuddin M. Rafeeq. Misbahuddin M. Rafeeq is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aslam, Muhammad, et al.. (2025). A Novel Homozygous Loss-of-Function Variant in GPR156 Delineates Non-syndromic Hearing Loss. Biochemical Genetics. 64(1). 89–95. 1 indexed citations
2.
Rafeeq, Misbahuddin M., et al.. (2025). Anticancer potential of dietary fiber for colorectal carcinoma: a narrative review. Annals of Medicine. 57(1). 2583756–2583756.
3.
Rafeeq, Misbahuddin M., Fahad A. Al‐Abbasi, Muhammad Afzal, et al.. (2025). Effects of a Rosiridin against Rotenone-induced Rats Model of Parkinson's Disease: In-vivo Study and in silico Molecular Modeling. Current Neuropharmacology. 23(9). 1095–1118.
4.
5.
Gilani, Sadaf Jamal, Ehssan Moglad, Muhammad Afzal, et al.. (2025). Exploring the therapeutic potential of aloenin-loaded nanogel for imiquimod-induced psoriasis-like skin conditions: In vitro and in vivo assessment. Journal of Pharmacology and Experimental Therapeutics. 392(9). 103647–103647.
6.
7.
Rafeeq, Misbahuddin M., Fahad A. Al‐Abbasi, Muhammad Afzal, et al.. (2024). 6-Shogaol Abrogates Parkinson’s Disease in Rotenone-Induced Rodents: Based on In Silico Study and Inhibiting TNF-α/NF-κB/IL-1β/MAO-B. Pharmaceuticals. 17(10). 1348–1348. 3 indexed citations
8.
9.
Ahmad, Shaban, et al.. (2022). Reporting dinaciclib and theodrenaline as a multitargeted inhibitor against SARS-CoV-2: an in-silico study. Journal of Biomolecular Structure and Dynamics. 41(9). 4013–4023. 39 indexed citations
10.
Hussain, Talib, Misbahuddin M. Rafeeq, El‐Sayed Khafagy, et al.. (2022). Oleuropein as a Potent Compound against Neurological Complications Linked with COVID-19: A Computational Biology Approach. Entropy. 24(7). 881–881. 6 indexed citations
11.
He, Shan, Abdulraheem Ali Almalki, Misbahuddin M. Rafeeq, et al.. (2022). Targeting Cytotoxin-Associated Antigen A, a Virulent Factor of Helicobacter pylori-Associated Gastric Cancer: Structure-Based In Silico Screening of Natural Compounds. Molecules. 27(3). 732–732. 6 indexed citations
12.
Ahmad, Faizan, Punya Sachdeva, Hemant Soni, et al.. (2022). Dioxinodehydroeckol: A Potential Neuroprotective Marine Compound Identified by In Silico Screening for the Treatment and Management of Multiple Brain Disorders. Molecular Biotechnology. 66(4). 663–686. 6 indexed citations
13.
Rafeeq, Misbahuddin M.. (2022). Molecular docking analysis of phytochemicals with estrogen receptor alpha. Bioinformation. 18(8). 697–702. 1 indexed citations
14.
Rahaman, Abdul, Abdulraheem Ali Almalki, Misbahuddin M. Rafeeq, et al.. (2021). Identification of Potent Natural Resource Small Molecule Inhibitor to Control Vibrio cholera by Targeting Its Outer Membrane Protein U: An In Silico Approach. Molecules. 26(21). 6517–6517. 4 indexed citations
15.
Ahmad, Farooq, Qamre Alam, Tanveer Ahmad, et al.. (2021). Variants in the <b><i>PNPLA1</i></b> Gene in Families with Autosomal Recessive Congenital Ichthyosis Reveal Clinical Significance. Molecular Syndromology. 12(6). 351–361. 3 indexed citations
16.
Tayeb, Haythum O., Hussam Murad, Misbahuddin M. Rafeeq, & Frank I. Tarazi. (2018). Pharmacotherapy of schizophrenia: toward a metabolomic-based approach. CNS Spectrums. 24(3). 281–286. 11 indexed citations
17.
Rafeeq, Misbahuddin M. & Hussam Murad. (2017). Cystic fibrosis: current therapeutic targets and future approaches. Journal of Translational Medicine. 15(1). 132 indexed citations
18.
Murad, Hussam & Misbahuddin M. Rafeeq. (2016). Pattern of use and awareness of contents, benefits and adverse effects of energy drinks among university students in Rabigh, Saudi Arabia.. Biomedical Research-tokyo. 27(2). 0. 4 indexed citations
19.
Rafeeq, Misbahuddin M. & Hamed Habib. (2014). Pannexin Channels: The Emerging Therapeutic Targets. Current Drug Targets. 15(3). 272–280. 6 indexed citations
20.
Rafeeq, Misbahuddin M., et al.. (2013). Dyslipidemic drugs in metabolic syndrome. Indian Journal of Endocrinology and Metabolism. 17(3). 472–479. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuzhi Wang Breakdown of academic impact, for papers by Yiheng Wang Breakdown of academic impact, for papers by Zhe Meng Breakdown of academic impact, for papers by Thomas M. Moon Breakdown of academic impact, for papers by Zeqi Su Breakdown of academic impact, for papers by Sandro Satta Breakdown of academic impact, for papers by José Manuel Cóndor Capcha Breakdown of academic impact, for papers by Hisashi Nagai Breakdown of academic impact, for papers by Lili Dong
Rankless by CCL
2026